Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Atrial fibrillation.

  2022cited by this paper
• Rate versus rhythm control in atrial fibrillation.

  2013cited by this paper
• New Approaches to Atrial Fibrillation Management

  2012cited by this paper
• Long-term efficacy of flecainide in paroxysmal atrial fibrillation.

  2009cited by this paper
• Drug-induced Brugada syndrome.

  2009cited by this paper
• Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation.

  2009cited by this paper
• Wolff-Parkinson-White syndrome. A long-term follow-up of 47 cases.

  2009cited by this paper
• The surgical treatment of atrial fibrillation.

  2009cited by this paper
• Chronic atrial fibrillation. Long-term results of direct current conversion.

  2009cited by this paper
• Direct current countershock complications.

  2009cited by this paper
• New Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation

  2008cited by this paper
• Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

  2006cited by this paper
• Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis

  2006cited by this paper
• Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal.

  2006cited by this paper
• Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation: A Randomized Comparison Between 2 Current Ablation Strategies

  2005cited by this paper
• The Junction Between the Left Atriuni and the Pulmonary Veins An Anatomic Study of Human Hearts

  2005cited by this paper
• Spectral Analysis Identifies Sites of High-Frequency Activity Maintaining Atrial Fibrillation in Humans

  2005cited by this paper
• Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

  2005cited by this paper
• Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.

  2005cited by this paper
• Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.

  2005cited by this paper
• Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.

  2005cited by this paper
• Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation.

  2005cited by this paper
• Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.

  2005cited by this paper
• Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas

  2005cited by this paper
• Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

  2005cited by this paper
• Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.

  2005cited by this paper
• Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study

  2005cited by this paper
• Obesity and the risk of new-onset atrial fibrillation.

  2005cited by this paper
• Prophylaxis against postoperative atrial fibrillation: current progress and future directions.

  2005cited by this paper
• Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

  2005cited by this paper
• Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.

  2005cited by this paper
• Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack

  2005cited by this paper
• Role of Permanent Pacing to Prevent Atrial Fibrillation on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Heart Rhythm Society

  2005cited by this paper
• Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

  2005cited by this paper
• Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

  2005cited by this paper
• Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

  2005cited by this paper
• Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease

  2005cited by this paper
• Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.

  2005cited by this paper
• Increased Intensity of Anticoagulation May Reduce Risk of Thrombus During Atrial Fibrillation Ablation Procedures in Patients with Spontaneous Echo Contrast

  2005cited by this paper
• Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence

  2005cited by this paper
• Obesity and Risk of New-Onset Atrial Fibrillation After Cardiac Surgery

  2005cited by this paper
• Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

  2005cited by this paper
• Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

  2005cited by this paper
• N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.

  2005cited by this paper
• Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No Previous History of Stroke or Transient Ischemic Attacks

  2005cited by this paper
• Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the

  2005cited by this paper
• Amiodarone versus sotalol for atrial fibrillation.

  2005cited by this paper
• Atrial Ultrastructural Changes During Experimental Atrial Tachycardia Depend on High Ventricular Rate

  2004cited by this paper
• Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation

  2004cited by this paper
• Pharmacological approaches in the treatment of atrial fibrillation.

  2004cited by this paper
• The Impact of Atrial Prevention and Termination Therapies on Atrial Tachyarrhythmia Burden in Patients Receiving a Dual-Chamber Defibrillator for Ventricular Arrhythmias

  2004cited by this paper
• Prevention of Iatrogenic Atrial Tachycardia After Ablation of Atrial Fibrillation: A Prospective Randomized Study Comparing Circumferential Pulmonary Vein Ablation With a Modified Approach

  2004cited by this paper
• Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment.

  2004cited by this paper
• Postoperative atrial fibrillation and mortality after coronary artery bypass surgery.

  2004cited by this paper
• Atrial fibrillation after radiofrequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics

  2004cited by this paper
• Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial

  2004cited by this paper
• Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation

  2004cited by this paper
• Pharmacological rate control of atrial fibrillation.

  2004cited by this paper
• Left Atrial–Esophageal Fistula Following Radiofrequency Catheter Ablation of Atrial Fibrillation

  2004cited by this paper
• Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin

  2004cited by this paper
• Obesity and atrial fibrillation: is one epidemic feeding the other?

  2004cited by this paper
• Electrophysiologic and electroanatomic changes in the human atrium associated with age.

  2004cited by this paper
• Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.

  2004cited by this paper
• Techniques for Curative Treatment of Atrial Fibrillation

  2004cited by this paper
• Increased Myocardial Collagen Content in Transgenic Rats Overexpressing Cardiac Angiotensin-Converting Enzyme Is Related to Enhanced Breakdown of N-Acetyl-Ser-Asp-Lys-Pro and Increased Phosphorylation of Smad2/3

  2004cited by this paper
• Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation.

  2004cited by this paper
• Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses.

  2004cited by this paper
• Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.

  2004cited by this paper
• “Early” Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat

  2004cited by this paper
• The Who, What, Why, and How‐To Guide for Circumferential Pulmonary Vein Ablation

  2004cited by this paper
• Autonomic nervous system and paroxysmal atrial fibrillation: a study based on the analysis of RR interval changes before, during and after paroxysmal atrial fibrillation.

  2004cited by this paper
• Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial

  2004cited by this paper
• Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.

  2004cited by this paper
• Pharmacology of cardiac potassium channels.

  2004cited by this paper
• A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate.

  2004cited by this paper
• Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

  2004cited by this paper
• A multicenter risk index for atrial fibrillation after cardiac surgery.

  2004cited by this paper
• Advances in surgical treatment of atrial fibrillation.

  2004cited by this paper
• The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial.

  2004cited by this paper
• Cost of care distribution in atrial fibrillation patients: the COCAF study.

  2004cited by this paper
• Mortality in Patients After a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification

  2004cited by this paper
• Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation

  2004cited by this paper
• Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.

  2004cited by this paper
• Presence of Left-to-Right Atrial Frequency Gradient in Paroxysmal but Not Persistent Atrial Fibrillation in Humans

  2004cited by this paper
• Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension.

  2004cited by this paper
• Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms.

  2004cited by this paper
• Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

  2004cited by this paper
• Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study

  2004cited by this paper
• Cardiac surgery for arrhythmias.

  2004cited by this paper
• Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Atrial Fibrillation Originating From Persistent Left Superior Vena Cava

  2004cited by this paper
• Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.

  2004cited by this paper
• Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia

  2004cited by this paper
• Fish intake and risk of incident atrial fibrillation.

  2004cited by this paper
• Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial Fibrillation

  2004cited by this paper
• Reversal of Electrical Remodeling After Cardioversion of Persistent Atrial Fibrillation

  2004cited by this paper
• Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.

  2004cited by this paper
• Theoretical possibilities for the development of novel antiarrhythmic drugs.

  2004cited by this paper
• Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study.

  2004cited by this paper
• Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation

  2004cited by this paper

• Atrial fibrillation episode status and incidence of coronary slow flow: A propensity score-matched analysis

  2023cites this paper
• Colchicine for prevention of post-operative atrial fibrillation: Meta-analysis of randomized controlled trials

  2022cites this paper
• Sudden death by arritmogenic displasia of the right ventricule in immediate post-operative: case report

  2020cites this paper
• Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: a retrospective observational study in Southern Italy

  2018cites this paper
• Elevated plasma levels of Th17-related cytokines are associated with increased risk of atrial fibrillation

  2016cites this paper
• Novel Anticoagulants in Atrial Fibrillation: A Primer for the Primary Physician

  2015cites this paper
• The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice

  2014cites this paper
• Score for atrial fibrillation detection in acute stroke and transient ischemic attack patients in a Brazilian population: The acute stroke atrial fibrillation scoring system

  2014cites this paper
• Utilisation des bases médico-administratives dans la surveillance des effets indésirables : patients porteurs d’une fibrillation auriculaire et dabigatran

  2014cites this paper
• Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-making

  2014cites this paper
• Oral Anticoagulants to Reduce the Risk of Stroke in Atrial Fibrillation: How Should a Clinician Choose?

  2013cites this paper
• Co-existence of Atrial Fibrillation with Myocardial Infarction - Unhealthy Combination.

  2012cites this paper
• Clinical trials of direct thrombin and factor Xa inhibitors in atrial fibrillation

  2011cites this paper
• Fibrillation : a Primary care cross-sectional study

  2011cites this paper
• Calidad de vida en pacientes con fibrilación auricular

  2010cites this paper